Readystate Asset Management »

Travere Therapeutics shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.7M 333k 13.99

More positions owned by Readystate Asset Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Granite Constr Note 3.750% 5/1 (Principal)
Transmedics Group Note 1.500% 6/0 (Principal)
Hess (HES)
Freshpet Note 3.000% 4/0 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Workiva Note 1.250% 8/1 (Principal)
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
Impinj Note 1.125% 5/1 (Principal)
Walt Disney Company (DIS)
Alphabet Cap Stk Cl C (GOOG)
Dayforce Note 0.250% 3/1 (Principal)
NVIDIA Corporation Call Option (NVDA)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)

View all positions for Readystate Asset Management

Top funds holding Travere Therapeutics

BlackRock
BlackRock
Armistice Capital
Deep Track Capital
Vanguard Group
Rock Springs Capital Management
Macquarie Group
Woodline Partners
State Street Corporation
Morgan Stanley
Kynam Capital Management
Emerald Advisers
Renaissance Technologies
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Travere Therapeutics